Survival rates for non-Hodgkin and Hodgkin lymphoma Medically reviewed by Julie Scott, DNP, ANP-BC, AOCNP — Written by Beth Sissons — Updated on July 11, 2025 Factors affecting outlook ...

Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- ...

Stage 3 lymphoma is a lymphatic cancer that has spread to lymph nodes above and below the diaphragm. Learn its symptoms, ...

The overall five-year relative survival rate for non-Hodgkin lymphoma is 74.3 percent. [30] It accounts for 3.3 percent of all cancer deaths. ... Other non-Hodgkin lymphomas, like B-cell lymphoma; ...

The study involves testing epcoritamab, administered subcutaneously, in combination with oral and intravenous anti-neoplastic agents. These include drugs like lenalidomide, ibrutinib, and polatuzumab ...

Chong EA, Ruella M, Schuster SJ. Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy. N Engl J Med. 2021;384(7):673–4. Raj SS, Fei T, Fried S, et al. An inflammatory biomarker ...

You may be able to join this trial if all of the following apply. You: have a mature B cell lymphoma such as diffuse large B cell lymphoma (DLBCL), Burkitt lymphoma, Burkitt leukaemia, atypical ...

Stage 3 non-Hodgkin lymphoma means the cancer has not spread outside the lymphatic system, according to the American Cancer Society. The five-year survival rate for B-cell non-Hodgkin lymphoma ...

Antibody–Drug Conjugates for the Treatment of B-cell Non–Hodgkin's Lymphoma and Leukemia. ... hBU12-vcMMAE exhibited significant activity as measured by tumor reduction and survival indices ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

Treatment with Yescarta for B-cell lymphoma may be promising within the first five years, but the risk of secondary cancers may reduce survival long term. Short-term outcomes following treatment with ...

To the Editor: It has been suggested that nodular lymphocyte-predominant Hodgkin's disease and T-cell–rich B-cell lymphoma are closely related entities.1 Indeed, the lymphocytic and histiocytic ...